DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Hartford Investment Management Co.


Hartford Investment Management Co. reduced its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating ) by 7.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,569 shares of the medical instruments supplier’s stock after selling 1,609 shares during the period. Hartford Investment Management Co.’s holdings. in DENTSPLY SIRONA were worth $1,012,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. NuWave Investment Management LLC boosted its holdings in DENTSPLY SIRONA by 172.8% in the 4th quarter. NuWave Investment Management LLC now owns 502 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 318 shares during the last quarter. SOA Wealth Advisors LLC. grew its holdings in DENTSPLY SIRONA by 26,666.7% in the first quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier’s stock valued at $39,000 after buying an additional 800 shares in the last quarter. National Bank of Canada FI acquired a new stake in DENTSPLY SIRONA in the 4th quarter valued at $55,000. Dixon Hughes Goodman Wealth Advisors LLC acquired a new stake in DENTSPLY SIRONA in the 1st quarter valued at $79,000. Finally, Covestor Ltd acquired a new stake in DENTSPLY SIRONA in the 4th quarter valued at $90,000. Hedge funds and other institutional investors own 94.79% of the company’s stock.

In other news, Director Eric Brandt sold 6,900 shares of the company’s stock in a transaction on Tuesday, May 3rd. The shares were sold at an average price of $39.71, for a total value of $273,999.00. Following the completion of the sale, the director now owns 35,155 shares in the company, valued at $1,396,005.05. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.76% of the company’s stock.

Several brokerages have recently issued reports on XRAY. HC Wainwright reduced their target price on DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating for the company in a report on Friday, April 22nd. Bank of America cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and reduced their target price for the company from $66.00 to $49.00 in a research report on Tuesday, April 19th. Morgan Stanley decreased their price objective on shares of DENTSPLY SIRONA from $62.00 to $52.00 and set an “overweight” rating for the company in a research report on Wednesday, April 20th. Piper Sandler reissued a “neutral” rating and issued a $46.00 target price (down from $71.00) on shares of DENTSPLY SIRONA in a research report on Wednesday, April 20th. Finally, The Goldman Sachs Group reduced their price objective on shares of DENTSPLY SIRONA from $59.00 to $47.00 and set a “neutral” rating for the company in a research report on Thursday, April 21st. Six analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com DENTSPLY SIRONA currently has an average rating of “Hold” and an average price target of $50.56.

Shares of XRAY stock opened at $36.20 on Tuesday. The company has a debt-to-equity ratio of 0.38, a quick earnings ratio of 1.03 and a current ratio of 1.45. The company’s 50-day simple moving average is $38.32, and its 200-day simple moving average is $47.24. DENTSPLY SIRONA Inc. has a one year low of $33.78 and a one year high of $66.98. The stock has a market cap of $7.80 billion, a price-to-earnings ratio of 21.42 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings data on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $9.67 billion during the quarter, compared to analyst estimates of $982.05 million. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The company’s revenue increased by 841.1% year-over-year. In the same quarter last year, the firm posted earnings of $0.72 per share. As a group, analysts predict that DENTSPLY SIRONA Inc. will post 2.42 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 8th. Shareholders of record on Friday, June 24th will be given a $0.125 dividend. The ex-dividend date is Thursday, June 23rd. This represents a $0.50 annual dividend and a dividend yield of 1.38%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 29.59%.

About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes and markets a variety of dental products and technologies for the professional dental market worldwide. Offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces and other instruments; imaging equipment; treatment centers including basic dental chairs, advanced chair-based units with integrated diagnostic, hygiene and ergonomic functions and specialized centers; and laboratory equipment, such as amalgamators, mixing machines and porcelain furnaces.

Featured stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)



Get DENTSPLY SIRONA news and reviews every day – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DENTSPLY SIRONA and related companies with MarketBeat.com ‘s FREE daily email newsletter.

Leave a Comment

Your email address will not be published.